Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
small molecule |
| gptkbp:administeredBy |
oral
|
| gptkbp:ATCCode |
none (not assigned)
|
| gptkbp:CASNumber |
915769-50-5
|
| gptkbp:chemicalFormula |
C24H26N4O2
|
| gptkbp:developedBy |
gptkb:Novartis
|
| gptkbp:hasInChIKey |
QJQYQJQYQJQYQJ-UHFFFAOYSA-N
|
| gptkbp:hasSMILES |
CC1=CC2=C(C=C1)N=C(N2)N3CCN(CC3)C4=CC(=C(C=C4)OC)OC
|
| gptkbp:hasUNII |
6Z5B6HVF6O
|
| https://www.w3.org/2000/01/rdf-schema#label |
Dovitinib
|
| gptkbp:investigatedBy |
gptkb:cancer
hepatocellular carcinoma renal cell carcinoma |
| gptkbp:mechanismOfAction |
gptkb:receptor_tyrosine_kinase
|
| gptkbp:molecularWeight |
402.49 g/mol
|
| gptkbp:PubChem_CID |
CHEMBL354494
11282183 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:status |
investigational
|
| gptkbp:synonym |
CHIR-258
TKI-258 TKI258 |
| gptkbp:target |
gptkb:PDGFR
gptkb:VEGFR gptkb:FGFR3 gptkb:FGFR1 gptkb:FGFR2 |
| gptkbp:bfsParent |
gptkb:CD332
|
| gptkbp:bfsLayer |
7
|